David
Jiménez Castro
Profesor/a Titular Universidad
University of Michigan Medical School
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan Medical School (9)
2024
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review
Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865
-
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials
Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 16-30
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment
American journal of respiratory and critical care medicine, Vol. 208, Núm. 5, pp. 524-527
2022
-
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review
JAMA Cardiology, Vol. 7, Núm. 7, pp. 747-759
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477